These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Haimei MA Clin Appl Thromb Hemost; 2021; 27():10760296211040110. PubMed ID: 34541935 [TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil. Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M; Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962 [TBL] [Abstract][Full Text] [Related]
5. Management of a severe bilateral pulmonary embolism as a complication of VITT following vaccination with AstraZeneca COVID-19 vaccine. Elkoumy M; Schoen J; Loew A BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35545306 [TBL] [Abstract][Full Text] [Related]
6. Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations. Laffan MA; Rees S; Yadavalli M; Ferstenberg LB; Kumar Shankar N; Medin J; Foskett N; Arnold M; Gomes da Silva H; Bhuyan P; Nord M Vaccine; 2022 Sep; 40(38):5585-5593. PubMed ID: 35989136 [TBL] [Abstract][Full Text] [Related]
7. Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. Maramattom BV; Moidu FM; Varikkottil S; Syed AA BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34706921 [TBL] [Abstract][Full Text] [Related]
8. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217 [TBL] [Abstract][Full Text] [Related]
9. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. Soltani Hekmat A; Javanmardi K Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086 [TBL] [Abstract][Full Text] [Related]
10. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148 [TBL] [Abstract][Full Text] [Related]
11. Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Varona JF; García-Isidro M; Moeinvaziri M; Ramos-López M; Fernández-Domínguez M Eur J Intern Med; 2021 Sep; 91():90-92. PubMed ID: 34256983 [No Abstract] [Full Text] [Related]
12. Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure. Wittstock M; Walter U; Volmer E; Storch A; Weber MA; Großmann A Neuroradiology; 2022 May; 64(5):865-874. PubMed ID: 35184205 [TBL] [Abstract][Full Text] [Related]
14. Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 Vaccinated Individuals. Ornelas-Aguirre JM; Gómez-Alcalá AV; Ramírez-Leyva DH Arch Med Res; 2022 Jun; 53(4):341-351. PubMed ID: 35534335 [TBL] [Abstract][Full Text] [Related]
15. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. Long B; Bridwell R; Gottlieb M Am J Emerg Med; 2021 Nov; 49():58-61. PubMed ID: 34062319 [TBL] [Abstract][Full Text] [Related]
16. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia. MacIntyre CR; Veness B; Berger D; Hamad N; Bari N Vaccine; 2021 Aug; 39(34):4784-4787. PubMed ID: 34272095 [TBL] [Abstract][Full Text] [Related]
17. Generalized Edema and Pseudothrombocytopenia After ChAdOx1 nCoV-19 COVID-19 Vaccination: A Case Report. Bokel J; Mendes-de-Almeida DP; Martins-Gonçalves R; Palhinha L; Vizzoni AG; Correa DF; Brandão LGP; Bozza PT; Grinsztejn B Front Public Health; 2022; 10():907652. PubMed ID: 35692333 [TBL] [Abstract][Full Text] [Related]
19. Unusual Fever, Headache, and Abdominal Pain in a Healthy Woman. Lin CY; Wang CH; Hsiao PJ Gastroenterology; 2021 Nov; 161(5):1387-1389. PubMed ID: 34339677 [No Abstract] [Full Text] [Related]
20. Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan. Chen CY; Chen TT; Hsieh CY; Lien MY; Yeh SP; Chen CC Int J Hematol; 2023 Jan; 117(1):149-152. PubMed ID: 36057889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]